Cannabis for dogs? A look behind the CBD pet treat trend
As the fireworks went off, Gus stayed still, calm, “chilled out.”
As the fireworks went off, Gus stayed still, calm, “chilled out.”
Advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD) are chronic conditions with significant associated morbidity and mortality. Patients experience substantial symptom burden that is frequently undertreated due to adverse medication side effects. This article reviews the available evidence for the use of medical marijuana to manage chronic pain, nausea/vomiting, anorexia/cachexia, and pruritus, all of which are frequently reported by patients with advanced chronic kidney disease or end-stage renal disease.
The bill, known as Let Doctors Decide, went into effect immediately after being signed on March 9.
This is an “interesting and important study”
Pain associated with integumentary wounds is highly prevalent, yet it remains an area of significant unmet need within health care. Currently, systemically administered opioids are the mainstay of treatment. The ideal methods of pain relief for wound patients are modalities that are topical, lack systemic side effects, noninvasive, self-administered, and display rapid onset of analgesia. Extracts derived from the cannabis plant have been applied to wounds for thousands of years.
Cannabis can regrow brain cells, so the argument goes. It’s become a favorite claim for supporters of medical weed, but there’s a catch.
“PHYSICIAN PARTICIPATION IS VITAL TO THE SUCCESS OF THIS PROGRAM.”
Trials of a CBD-based pill have yet to finish – but studies have shown compounds in cannabis can help eczema and psoriasis patients.
Our ultimate aim should be to scientifically establish the actual place of medical cannabis-derived products in the modern medical arsenal
Several jurisdictions around the world have introduced policies and laws allowing for the legal use of cannabis for therapeutic purposes. However, there has been little critical discussion of how the object of ‘medicinal cannabis’ is enacted in policy and practice. Informed by Carol Bacchi’s poststructuralist approach to policy analysis and the work of science and technology studies scholars, this paper seeks to problematise the object of ‘medicinal cannabis’ and examine how it is constituted through governing practices.